Notable companies
The most notable companies in this group are Chord Energy Corp (NASDAQ:CHRD), Intra-Cellular Therapies (NASDAQ:ITCI), Abercrombie & Fitch Co (NYSE:ANF), Valaris Limited (NYSE:VAL), KB Home (NYSE:KBH), StoneCo Ltd (NASDAQ:STNE), Signet Jewelers Limited (NYSE:SIG), Shake Shack (NYSE:SHAK), Goodyear Tire & Rubber Company (The) (NASDAQ:GT), Scorpio Tankers (NYSE:STNG).
Industry description
The investment seeks investment results that correspond generally to the price and yield performance of the Cboe Russell 2000 Half BuyWrite Index.
The fund invests at least 80% of its net assets in the securities of the index or in investments that have economic characteristics that are substantially identical to the economic characteristics of such component securities, either individually or in the aggregate. The index measures the performance of a covered call strategy that holds a theoretical portfolio of the underlying stocks of the Russell 2000 Index and "writes" (or sells) a succession of one-month ATM covered call options on the Reference Index.
Market Cap
The average market capitalization across the Global X Russell 2000 Cov Cl & Gr ETF ETF is 1.73B. The market cap for tickers in the group ranges from 3.36M to 59.14B. SMCI holds the highest valuation in this group at 59.14B. The lowest valued company is BIG at 3.36M.
High and low price notable news
The average weekly price growth across all stocks in the Global X Russell 2000 Cov Cl & Gr ETF ETF was -0%. For the same ETF, the average monthly price growth was 3%, and the average quarterly price growth was 5%. EVGO experienced the highest price growth at 72%, while EGRX experienced the biggest fall at -77%.
Volume
The average weekly volume growth across all stocks in the Global X Russell 2000 Cov Cl & Gr ETF ETF was -9%. For the same stocks of the ETF, the average monthly volume growth was 6% and the average quarterly volume growth was 21%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 59
P/E Growth Rating: 56
Price Growth Rating: 54
SMR Rating: 70
Profit Risk Rating: 74
Seasonality Score: 40 (-100 ... +100)